Aarhus University Seal / Aarhus Universitets segl

FOCUSING ON BIOMARKERS AND TARGET VALIDATION

The two research areas Biomarkers and Target Validation have been selected for the initial wave of projects funded by ODIN with the aim to potentially leading to new downstream therapeutics. These themes  were selected after close dialogue with industry partners and because both address key barriers to early drug discovery that are difficult to overcome but are strong indicators of success in creating new medicines. Furthermore, these focus areas require standardisation of experimental protocols and data management, which is best performed in an open environment and ODIN projects will thus have the potential to lead to better therapeutic treatments with market value

You can find a more thorough description of the overall aims of these two initial themes by following the links to the right, but in brief their aims are to:

Biomarkers

• Discover lead biomarkers for multiple diseases. 

• Drive improvements of early diagnosis, enhanced prediction of disease progression and greater application of personalized medicine - but always with the overall purpose of creating building blocks for subsequent drug discovery for pharma industry. 

Target Validation

• Develop human model systems and evaluation methods for target validation in early drug discovery. 

• Reduce off-target drug effects and maximize the chance of success of new therapies in patients. 

OPEN WORK TAKES PLACE AT A SEPERATE COLLABORATION PLATFORM

Please note that you need an invitation to join us. You can contact Ditte Engholm (dhe@au.dk) for more details.

Link to our collaboration platform